HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1

CUSIP: 44052TAB7

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Debt / NOTE 2.500% 3/1
Market price (% of par)
86.25%
Total 13F principal
$344,131,500
Principal change
-$29,501,000
Total reported market value
$299,925,725
Number of holders
29
Value change
-$28,608,102
Number of buys
14
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 44052TAB7?
CUSIP 44052TAB7 identifies 44052TAB7 - HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 as of Q2 2017

As of 30 Jun 2017, HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 was held by 29 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $344,131,500 in principal (par value) of the bond. The largest 10 bondholders included DEERFIELD MANAGEMENT CO, ADVENT CAPITAL MANAGEMENT /DE/, KINGDON CAPITAL MANAGEMENT, L.L.C., CANYON CAPITAL ADVISORS LLC, LINDEN ADVISORS LP, PRUDENTIAL PLC, Lion Point Capital, LP, AMERIPRISE FINANCIAL INC, Invesco Ltd., and SILVERBACK ASSET MANAGEMENT LLC. This page lists 29 institutional bondholders reporting positions for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.